Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly(butylcyanoacrylate)

Colloid and Polymer Science

Volumn 288, Issue 8, 2010, Pages 893-899

  Yordanov, Georgi G ^a   Bedzhova, Zorka A ^a   Dushkin, Ceco D ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Chlorambucil; Emulsion polymerization; Nanoparticles; Poly(butylcyanoacrylate)

Indexed keywords

CANCER CELLS; CHEMICAL COMPOSITIONS; CHEMICAL INSTABILITY; CHLORAMBUCIL; CHRONIC LYMPHOCYTIC LEUKEMIAS; DRUG CARRIER SYSTEMS; DRUG CONTENT; DRUG RELEASE; LIPOPHILIC DRUGS; LOW TOXICITY; MALIGNANT DISEASE; MULTIDRUG RESISTANCE; NANO-SIZED; PHYSICO-CHEMICAL CHARACTERIZATION; POLY(BUTYLCYANOACRYLATE); TOXIC SIDE EFFECTS;

BIOCOMPATIBILITY; BIODEGRADATION; EMULSIFICATION; EMULSION POLYMERIZATION; TOXICITY;

NANOPARTICLES;

CHLORAMBUCIL; NANOPARTICLE; POLY(BUTYLCYANOACRYLATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER CELL; CHEMICAL COMPOSITION; DRUG ANALYSIS; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; KINETICS; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; THIN LAYER CHROMATOGRAPHY;

EID: 77956488214     PISSN: 0303402X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00396-010-2219-5     Document Type: Article

References (33)

1. Vasir J, Reddy M, Labhasetwar V (2005) Curr Nanosci 1:47-64
2. Briesen H, Ramge P, Kreuter J (2000) AIDS Rev 2:31-38
3. Briones E, Colino CI, Lanao J (2008) J Control Release 125:210-227
4. Salata OV (2004) J Nanobiotechnology 2:3
5. Brigger I, Dubernet C, Couvreur P (2002) Adv Drug Deliv Rev 54:631-651
6. Praetorius NP, Mandal TK (2007) Recent Pat Drug Deliv Formul 1:37-51
7. Brannon-Peppas L, Blanchette JO (2004) Adv Drug Deliv Rev 56:1649-1659
8. Barratt G (2003) Cell Mol Life Sci 60:21-37
9. Pinto-Alphandary H, Andremont A, Couvreur P (2000) Int J Antimicrob Agents 13:155-168
10. Murthy R, Reddy L (2006) Poly (alkyl cyanoacrylate) colloidal particles for delivery of anti-cancer drugs. In: Amiji MM (ed) Nanotechnology for cancer therapy. CRC, Boca Raton, pp 251-288
11. Ringe K, Walz C, Sabel B (2004) Nanoparticle drug delivery to the brain. In: Nalwa HS (ed) Encyclopedia of nanoscience and nanotechnology, vol 7. American Scientific, Valencia, pp 91-104
12. Begley D, Bradbury M, Kreuter J (2000) The blood-brain barrier and drug delivery to the CNS. Marcel Dekker, New York
13. Galton D, Israels L, Nabarro J, Till M (1965) BMJ II: 1172
14. Hall A, Tilby M (1992) Blood Rev 6:163-173
15. Owen W, Stewart P (1979) J Pharm Sci 68:992-996
16. Ehrsson H, Eksborg S, Wallin I, Nilsson S (1980) J Pharm Sci 69:1091-1094
17. Bosanquet A, Clarke H (1986) Cancer Chemother Pharmacol 18:176-179
18. Chatterji D, Yeager R, Gallelli J (1982) J Pharm Sci 71:50-54
19. Cullis P, Green R, Malone M (1995) J Chem Soc Perkin Trans 2:1503-1511
20. Salmaso S, Bersani S, Semenzato A, Caliceti P (2007) J Drug Target 15:379-390
21. Reux B, Weber V, Galmier M, Borel M, Madesclaire M, Madelmont J, Debiton E, Coudert P (2008) Bioorganic Med Chem 16:5004-5020
22. Pedersen P, Christensen M, Ruysschaert T, Linderoth L, Andresen T, Melander F, Mouritsen O, Madsen R, Clausen M (2009) J Med Chem 52:3408-3415
23. Ganta S, Paxton J, Baguley B, Garg S (2008) Int J Pharm 360:115-121
24. Sharma P, Ganta S, Denny W, Garg S (2009) Int J Pharm 367:187-194
25. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P (2003) Adv Drug Deliv Rev 55:519-548
26. Nicolas J, Couvreur P (2009) Wiley Interdiscipl Rev Nanomed Nanobiotechnol 1:111-127
27. Donnelly E, Johnston D, Pepper D, Dunn D (1977) J Polym Sci Polym Lett Ed 15:399-405
28. Behan N, Birkinshaw C (2000) Macromol Rapid Commun 21:884-886
29. Behan N, Birkinshaw C, Clarke N (2001) Biomaterials 22:1335-1344
30. Hawley A, Davis S, Illum L (1995) Adv Drug Deliv Rev 17:129-148
31. Moghimi S, Bonnemain B (1999) Adv Drug Deliv Rev 37:295-312
32. Nishioka Y, Yoshino H (2001) Adv Drug Deliv Rev 47:55-64
33. Oussoren C, Storm G (2001) Adv Drug Deliv Rev 50:143-156